| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447667 | European Journal of Cancer | 2011 | 5 Pages |
Abstract
Lenalidomide may be equally effective in heavily pre-treated multiple myeloma patients who are thalidomide-resistant or thalidomide-sensitive to a previous therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
T. Guglielmelli, S. Bringhen, S. Rrodhe, F. Gay, F. Cavallo, A. Berruti, V. Montefusco, E. Piro, G. Benevolo, M.T. Petrucci, T. Caravita, M. Offidani, P. Corradini, M. Boccadoro, G. Saglio, A. Palumbo,